Achievements

FEBRUARY 2026

• Our in-house Research & Development unit is officially recognized by the Department of Scientific and Industrial Research (DSIR), Government of India, reflecting our commitment to research excellence and innovation. This recognition reinforces our focus on developing high-quality biomedical solutions through rigorous experimentation, validation, and continuous improvement.
• At QRL Bioscience, we strive to push the boundaries of biomedical science while maintaining the highest standards of quality, ethics, and impact—working towards solutions that address real-world healthcare challenges.

FEBRUARY 2025

• TEST LICENCE APPROVED
• ONE MORE PATENT GRANTED

OCTOBER 2024

• FILED THE PATENT OF ADDITION
• FOLLOW UP INSPECTION BY CDSCO
• SUBMISSION OF REQUESTED DOCUMENTS TO CDSCO
• SUBMITTED A PATENT DRAFT FOR QRLBIO-002

AUGUST 2024

• JOINT INSPECTION BY REGULATORY AGENCIES

APRIL 2024

• MOVING TO A NEW FACILITY

JANUARY 2024

• RECEIVED SEED FUNDING FROM ANGEL INVESTORS

NOVEMBER 2023

• APPLIED FOR NEW DRUG TEST LICENSE

OCT 2023

• COMPLETED ADDIONAL STUDIES ON QRLBIO-001

APRIL 2023

• CONVERTED TO PVT LTD COMPANY

OCTOBER 2022

• RECEIVED SEED GRANT FROM GOVT. OF GUJARAT

MARCH 2021

• INCORPORATED AS LLP

DECEMBER 2021

• COMPETED R&D, VALIDATION OF PRODUCT QRLBIO-001

JANUARY 2020

• RECEIVED GRANT OF FROM DSIR AND STARTING R&D OF PRODUCT DEVELOPMENT